Piperazine sulfonamides as DPP-IV inhibitors: Synthesis, induced-fit docking and in vitro biological evaluation
Diabetes mellitus is a chronic illness that needs persistent medical attention and continuous patient self-management to avoid acute complications. Dipeptidyl peptidase-IV (DPP-IV) inhibitors minimize glucagon and blood glucose levels by increasing the incretin levels, glucagon-like peptide (GLP-1)...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Sciendo
2021-12-01
|
| Серии: | Acta Pharmaceutica |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.2478/acph-2021-0034 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|